ProgressImage ProgressImage
Sun Pharmaceutical Industries Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 524715 border-img ISIN Demat INE044A01036 border-img Book Value 101.44 border-img NSE Symbol SUNPHARMA border-img Div & Yield % 0.98 border-img Market Cap ( Cr.) 392567.19 border-img P/E 78.81 border-img EPS 20.76 border-img Face Value 1
Mar 2025
( Cr.)
Mar 2024
( Cr.)
Mar 2023
( Cr.)
Mar 2022
( Cr.)
Mar 2021
( Cr.)
Mar 2020
( Cr.)
SOURCES OF FUNDS :       
Share Capital 239.93239.93239.93239.93239.93239.93
Reserves Total 24099.9223454.4723508.4324348.0226698.5424156.29
Equity Share Warrants 0.000.000.000.000.000.00
Equity Application Money 0.000.000.000.000.000.00
Total Shareholders Funds 24339.8523694.4023748.3624587.9526938.4724396.22
Secured Loans 0.000.000.000.005.416.18
Unsecured Loans 11137.9611226.917790.825074.047352.716399.70
Total Debt 11137.9611226.917790.825074.047358.126405.88
Other Liabilities 618.221722.961105.451016.381342.131553.68
Total Liabilities 36096.0336644.2732644.6330678.3735638.7232355.78
APPLICATION OF FUNDS :       
Gross Block 18627.3418251.7417744.6817194.9815812.298244.71
Less : Accumulated Depreciation 11638.8210515.009033.017482.206143.503015.97
Less:Impairment of Assets 0.000.000.000.000.000.00
Net Block 6988.527736.748711.679712.789668.795228.74
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress 939.23766.11852.91828.641090.38596.61
Producing Properties 0.000.000.000.000.000.00
Investments 12410.1112429.9712613.2415548.8715537.2017361.72
Current Assets, Loans & Advances       
Inventories 3787.493423.623989.193403.743423.422633.67
Sundry Debtors 11701.438834.167125.024245.166585.246168.13
Cash and Bank Balance 910.50338.39421.28534.96360.98654.78
Loans and Advances 2322.562316.374708.001326.852329.442089.47
Total Current Assets 18721.9814912.5416243.499510.7112699.0811546.05
Less : Current Liabilities and Provisions       
Current Liabilities 6453.493811.447533.367524.566891.414956.61
Provisions 723.93609.08809.502562.551204.661097.94
Total Current Liabilities & Provisions 7177.424420.528342.8610087.118096.076054.55
Net Current Assets 11544.5610492.027900.63-576.404603.015491.50
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets 2030.601889.791982.841389.471969.401704.22
Deferred Tax Liability 862.96895.27950.451065.43631.95564.51
Net Deferred Tax 1167.64994.521032.39324.041337.451139.71
Other Assets 3045.974224.911533.794840.443401.892537.50
Total Assets 36096.0336644.2732644.6330678.3735638.7232355.78
Contingent Liabilities 1986.71941.731087.401031.723083.043439.72

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

x
x
×
Let's Chat
close
refresh